VAR Review with Dr. Bixby: Reversing the Call on MPAL
About this episode
In this episode, Anthony and Bernie are joined by the great Dr. Bixby to discuss the difficulties in the diagnosis and treatment of acute leukemias of mixed or ambiguous lineage (ALAL/MPAL).
We discuss:
- Diagnostic uncertainties and how the criteria for diagnosis have changed over the years
- Data behind the optimal treatment of MPAL and uncertainties in the literature
- Promising data for the FLAG-VIPR hybrid regimen and other novel treatment strategies
Get every episode summarized
Each time WolverHeme Happy Hour publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from WolverHeme Happy Hour
Bispecifics ate CAR-T's lunch: a multiple myeloma debate
WolverHeme Happy Hour
Episode 47: Cult-Like Thinking in BMT
WolverHeme Happy Hour
Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology
WolverHeme Happy Hour
HLH: From Chaos to Clarity... and Back to Chaos!
WolverHeme Happy Hour